A randomized trial of rizatriptan in migraine attacks in children

Neurology

Volumn 67, Issue 7, 2006, Pages 1135-1140

  Ahonen, K ^a   Hamalainen M L ^a   Eerola, M ^a   Hoppu, K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RIZATRIPTAN;

ADOLESCENT; ANKLE PAIN; ARTICLE; BODY WEIGHT; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FAINTNESS; FATIGUE; FEMALE; HEADACHE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; OUTPATIENT DEPARTMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; THROAT DISEASE; TREATMENT RESPONSE; VOMITING; XEROSTOMIA;

ADMINISTRATION, ORAL; ADOLESCENT; AMBULATORY CARE; CHILD; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FINLAND; HUMANS; MALE; MIGRAINE DISORDERS; PLACEBO EFFECT; SEROTONIN AGONISTS; TRIAZOLES; TRYPTAMINES;

EID: 33749827838     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000238179.79888.44     Document Type: Article

References (19)

1. Abu-Arafeh I, Russel G. Prevalence of headache and migraine in school children. BMJ 1994;309:765-769.
2. Mortimer M, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia 1992;12:238-243.
3. Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study. Neurology 1997;48:103-107.
4. Ahonen K, Hämäläinen ML, Rantala H, Hoppu K. Nasal sumatriptan is effective in treatment of migraine attacks in children- A randomized trial. Neurology 2004;62:883-887.
5. Hämäläinen ML, Hoppu K, Santavuori P. Sumatriptan for migraine attacks in children: a randomized placebo-controlled study. Do children with migraine respond to oral sumatriptan differently from adults. Neurology 1997;48:1100-1103.
6. Damen L, Bruijn JKJ, Verhagen AP, Berger MY, Passcher J, Koes BW. Symptomatic treatment of migraine in children: a systematic review of medication trials. Pediatrics 2005;116:295-302.
7. Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: Pharmacological treatment of migraine headache in children and adolescents. Report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology 2004;63:2215-2224.
8. Kramer MS, Matzura-Wolfe D, Polis A, et al. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group. Neurology 1998;51:773-781.
9. Block GA, Goldstein J, Polis A, Reines SA, Smith ME. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups. Headache 1998;38:764-771.
10. Winner P, Lewis D, Visser WH, Jiang K, Ahrens S, Evans JK. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study. Headache 2002;42:49-55.
11. Visser WH, Winner P, Strohmaier K, et al. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies. Headache 2004;44:891-899.
12. Headache Classification committee of the International Headache Society. Classification and diagnostic criteria for the headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:suppl 7.
13. Maunuksela E-L, Olkkola K, Korpela R. Measurements of pain in children with self-report and behavioral assessment. Clin Pharmacol Ther 1987;42:137-141.
14. Hills M, Armitage P. The two-period cross-over trial. Br J Clin Pharmacol 1979;8:7-20.
15. Wellington K, Plosker GL. Rizatriptan: an update of its use in the management of migraine. Drugs 2002;62:1539-1574.
16. Fuseau E, Petricoul O, Sabin A, et al. Effect of encapsulation on absorption of sumatriptan tablets: Data from healthy volunteers and patients during a migraine. Clin Ther 2001;23:242-251.
17. Lee Y, Conroy JA, Stepanavage ME, et al. Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers. Br J Clin Pharmacol 1999;47:373-378.
18. Cutler NR, Jhee SS, Majumdar AK, et al. Pharmacokinetics of rizatriptan tablets during and between migraine attacks. Headache 1999;39:264-269.
19. Gobel H, Heinze A, Heinze-Kuhn K, Lindner V. Efficacy and tolerability of rizatriptan 10 mg in migraine: experience with 70 527 patient episodes. Headache 2001;41:264-270.